nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—NR0B1—Vincristine—colon cancer	0.339	0.554	CbGbCtD
Tretinoin—CYP2A6—Fluorouracil—colon cancer	0.0381	0.0623	CbGbCtD
Tretinoin—CYP3A7—Irinotecan—colon cancer	0.0271	0.0444	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0271	0.0444	CbGbCtD
Tretinoin—CYP2B6—Irinotecan—colon cancer	0.0258	0.0423	CbGbCtD
Tretinoin—CYP3A7—Vincristine—colon cancer	0.0237	0.0388	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0237	0.0388	CbGbCtD
Tretinoin—CYP2C9—Capecitabine—colon cancer	0.0221	0.0361	CbGbCtD
Tretinoin—CYP3A5—Irinotecan—colon cancer	0.0204	0.0333	CbGbCtD
Tretinoin—CYP2C8—Fluorouracil—colon cancer	0.0188	0.0307	CbGbCtD
Tretinoin—CYP3A5—Vincristine—colon cancer	0.0178	0.0291	CbGbCtD
Tretinoin—CYP2C9—Fluorouracil—colon cancer	0.0131	0.0214	CbGbCtD
Tretinoin—CYP3A4—Irinotecan—colon cancer	0.00794	0.013	CbGbCtD
Tretinoin—CYP3A4—Vincristine—colon cancer	0.00694	0.0114	CbGbCtD
Tretinoin—GPRC5A—renal system—colon cancer	0.00551	0.0653	CbGeAlD
Tretinoin—GPRC5A—digestive system—colon cancer	0.00452	0.0536	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vincristine—colon cancer	0.0034	1	CbGdCrCtD
Tretinoin—ALDH1A1—gall bladder—colon cancer	0.00324	0.0384	CbGeAlD
Tretinoin—ALDH1A2—embryo—colon cancer	0.00282	0.0335	CbGeAlD
Tretinoin—CRABP1—embryo—colon cancer	0.00272	0.0323	CbGeAlD
Tretinoin—CRABP2—embryo—colon cancer	0.00246	0.0292	CbGeAlD
Tretinoin—ALDH1A2—renal system—colon cancer	0.00214	0.0253	CbGeAlD
Tretinoin—CYP4A11—renal system—colon cancer	0.00206	0.0244	CbGeAlD
Tretinoin—ALDH1A1—embryo—colon cancer	0.00205	0.0243	CbGeAlD
Tretinoin—RARRES1—vagina—colon cancer	0.00202	0.0239	CbGeAlD
Tretinoin—CRABP2—smooth muscle tissue—colon cancer	0.00194	0.023	CbGeAlD
Tretinoin—RXRA—renal system—colon cancer	0.00186	0.022	CbGeAlD
Tretinoin—CYP4A11—digestive system—colon cancer	0.00169	0.02	CbGeAlD
Tretinoin—ALDH1A1—smooth muscle tissue—colon cancer	0.00161	0.0191	CbGeAlD
Tretinoin—ALDH1A1—renal system—colon cancer	0.00155	0.0184	CbGeAlD
Tretinoin—ALDH1A2—vagina—colon cancer	0.00155	0.0183	CbGeAlD
Tretinoin—CRABP2—digestive system—colon cancer	0.00153	0.0181	CbGeAlD
Tretinoin—CRABP1—vagina—colon cancer	0.00149	0.0177	CbGeAlD
Tretinoin—CYP4A11—vagina—colon cancer	0.00149	0.0177	CbGeAlD
Tretinoin—CRABP2—vagina—colon cancer	0.00135	0.016	CbGeAlD
Tretinoin—ALDH1A2—liver—colon cancer	0.00131	0.0155	CbGeAlD
Tretinoin—RARRES1—lymph node—colon cancer	0.00131	0.0155	CbGeAlD
Tretinoin—ALDH1A1—lymphoid tissue—colon cancer	0.00129	0.0153	CbGeAlD
Tretinoin—RARA—renal system—colon cancer	0.00128	0.0152	CbGeAlD
Tretinoin—ALDH1A1—digestive system—colon cancer	0.00127	0.0151	CbGeAlD
Tretinoin—CYP4A11—liver—colon cancer	0.00126	0.0149	CbGeAlD
Tretinoin—RARB—vagina—colon cancer	0.00121	0.0143	CbGeAlD
Tretinoin—ALDH1A1—bone marrow—colon cancer	0.00117	0.0139	CbGeAlD
Tretinoin—RXRA—liver—colon cancer	0.00113	0.0134	CbGeAlD
Tretinoin—ALDH1A1—vagina—colon cancer	0.00113	0.0133	CbGeAlD
Tretinoin—CYP2C18—digestive system—colon cancer	0.00112	0.0133	CbGeAlD
Tretinoin—RARG—digestive system—colon cancer	0.00112	0.0132	CbGeAlD
Tretinoin—RXRB—vagina—colon cancer	0.00111	0.0132	CbGeAlD
Tretinoin—RARA—lymphoid tissue—colon cancer	0.00106	0.0126	CbGeAlD
Tretinoin—RARB—liver—colon cancer	0.00102	0.0121	CbGeAlD
Tretinoin—ALDH1A2—lymph node—colon cancer	0.001	0.0119	CbGeAlD
Tretinoin—CYP2C18—vagina—colon cancer	0.000989	0.0117	CbGeAlD
Tretinoin—RARG—vagina—colon cancer	0.000985	0.0117	CbGeAlD
Tretinoin—RARA—bone marrow—colon cancer	0.000967	0.0115	CbGeAlD
Tretinoin—ALDH1A1—liver—colon cancer	0.000949	0.0113	CbGeAlD
Tretinoin—RXRB—liver—colon cancer	0.000936	0.0111	CbGeAlD
Tretinoin—CYP2C18—liver—colon cancer	0.000835	0.00989	CbGeAlD
Tretinoin—CYP3A7—liver—colon cancer	0.000794	0.00941	CbGeAlD
Tretinoin—RARA—liver—colon cancer	0.000782	0.00926	CbGeAlD
Tretinoin—RARB—lymph node—colon cancer	0.000781	0.00926	CbGeAlD
Tretinoin—ALDH1A1—lymph node—colon cancer	0.000728	0.00863	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—liver—colon cancer	0.000675	0.008	CbGeAlD
Tretinoin—CYP2A6—vagina—colon cancer	0.000654	0.00775	CbGeAlD
Tretinoin—RARG—lymph node—colon cancer	0.000637	0.00755	CbGeAlD
Tretinoin—RARA—lymph node—colon cancer	0.000599	0.0071	CbGeAlD
Tretinoin—CYP2A6—liver—colon cancer	0.000552	0.00654	CbGeAlD
Tretinoin—CYP2C8—renal system—colon cancer	0.000507	0.00601	CbGeAlD
Tretinoin—CYP1A1—epithelium—colon cancer	0.000504	0.00598	CbGeAlD
Tretinoin—CYP1A1—renal system—colon cancer	0.000468	0.00554	CbGeAlD
Tretinoin—CYP3A5—renal system—colon cancer	0.000457	0.00542	CbGeAlD
Tretinoin—CYP2B6—renal system—colon cancer	0.000455	0.00539	CbGeAlD
Tretinoin—CYP1A1—digestive system—colon cancer	0.000384	0.00455	CbGeAlD
Tretinoin—CYP2B6—lymphoid tissue—colon cancer	0.000377	0.00447	CbGeAlD
Tretinoin—CYP3A5—digestive system—colon cancer	0.000375	0.00445	CbGeAlD
Tretinoin—CYP2B6—digestive system—colon cancer	0.000373	0.00442	CbGeAlD
Tretinoin—CYP2C9—digestive system—colon cancer	0.000369	0.00438	CbGeAlD
Tretinoin—CYP2C8—vagina—colon cancer	0.000367	0.00435	CbGeAlD
Tretinoin—CYP3A4—renal system—colon cancer	0.000343	0.00407	CbGeAlD
Tretinoin—CYP1A1—vagina—colon cancer	0.000339	0.00402	CbGeAlD
Tretinoin—CYP3A5—vagina—colon cancer	0.000331	0.00393	CbGeAlD
Tretinoin—CYP2B6—vagina—colon cancer	0.000329	0.0039	CbGeAlD
Tretinoin—CYP2C8—liver—colon cancer	0.00031	0.00367	CbGeAlD
Tretinoin—CYP1A1—liver—colon cancer	0.000286	0.00339	CbGeAlD
Tretinoin—CYP3A4—digestive system—colon cancer	0.000282	0.00334	CbGeAlD
Tretinoin—CYP3A5—liver—colon cancer	0.000279	0.00331	CbGeAlD
Tretinoin—CYP2B6—liver—colon cancer	0.000278	0.00329	CbGeAlD
Tretinoin—CYP2C9—liver—colon cancer	0.000275	0.00326	CbGeAlD
Tretinoin—CYP1A1—lymph node—colon cancer	0.000219	0.0026	CbGeAlD
Tretinoin—CYP3A4—liver—colon cancer	0.00021	0.00249	CbGeAlD
Tretinoin—Alitretinoin—ABCB1—colon cancer	0.000191	1	CrCbGaD
Tretinoin—Anaphylactic shock—Irinotecan—colon cancer	0.000167	0.000895	CcSEcCtD
Tretinoin—Oedema—Irinotecan—colon cancer	0.000167	0.000895	CcSEcCtD
Tretinoin—Chest pain—Fluorouracil—colon cancer	0.000167	0.000894	CcSEcCtD
Tretinoin—Myalgia—Fluorouracil—colon cancer	0.000167	0.000894	CcSEcCtD
Tretinoin—Infection—Irinotecan—colon cancer	0.000166	0.000889	CcSEcCtD
Tretinoin—Hyperhidrosis—Vincristine—colon cancer	0.000166	0.000889	CcSEcCtD
Tretinoin—Epistaxis—Capecitabine—colon cancer	0.000165	0.000886	CcSEcCtD
Tretinoin—Discomfort—Fluorouracil—colon cancer	0.000165	0.000884	CcSEcCtD
Tretinoin—Shock—Irinotecan—colon cancer	0.000164	0.000881	CcSEcCtD
Tretinoin—Nervous system disorder—Irinotecan—colon cancer	0.000164	0.000878	CcSEcCtD
Tretinoin—Agranulocytosis—Capecitabine—colon cancer	0.000164	0.000877	CcSEcCtD
Tretinoin—Thrombocytopenia—Irinotecan—colon cancer	0.000164	0.000876	CcSEcCtD
Tretinoin—Anorexia—Vincristine—colon cancer	0.000164	0.000876	CcSEcCtD
Tretinoin—Irritability—Methotrexate—colon cancer	0.000162	0.000866	CcSEcCtD
Tretinoin—Hyperhidrosis—Irinotecan—colon cancer	0.000162	0.000865	CcSEcCtD
Tretinoin—Confusional state—Fluorouracil—colon cancer	0.000161	0.000864	CcSEcCtD
Tretinoin—Mood swings—Methotrexate—colon cancer	0.00016	0.00086	CcSEcCtD
Tretinoin—Hypotension—Vincristine—colon cancer	0.00016	0.000859	CcSEcCtD
Tretinoin—Anaphylactic shock—Fluorouracil—colon cancer	0.00016	0.000857	CcSEcCtD
Tretinoin—Oedema—Fluorouracil—colon cancer	0.00016	0.000857	CcSEcCtD
Tretinoin—Anorexia—Irinotecan—colon cancer	0.000159	0.000853	CcSEcCtD
Tretinoin—Infection—Fluorouracil—colon cancer	0.000159	0.000852	CcSEcCtD
Tretinoin—Haemoglobin—Capecitabine—colon cancer	0.000158	0.000847	CcSEcCtD
Tretinoin—Haemorrhage—Capecitabine—colon cancer	0.000157	0.000843	CcSEcCtD
Tretinoin—Hepatitis—Capecitabine—colon cancer	0.000157	0.000843	CcSEcCtD
Tretinoin—Nervous system disorder—Fluorouracil—colon cancer	0.000157	0.000841	CcSEcCtD
Tretinoin—Thrombocytopenia—Fluorouracil—colon cancer	0.000157	0.000839	CcSEcCtD
Tretinoin—Hypoaesthesia—Capecitabine—colon cancer	0.000157	0.000839	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000156	0.000837	CcSEcCtD
Tretinoin—Pharyngitis—Capecitabine—colon cancer	0.000156	0.000837	CcSEcCtD
Tretinoin—Tachycardia—Fluorouracil—colon cancer	0.000156	0.000837	CcSEcCtD
Tretinoin—Hypotension—Irinotecan—colon cancer	0.000156	0.000836	CcSEcCtD
Tretinoin—Urinary tract disorder—Capecitabine—colon cancer	0.000155	0.000833	CcSEcCtD
Tretinoin—Insomnia—Vincristine—colon cancer	0.000155	0.000831	CcSEcCtD
Tretinoin—Oedema peripheral—Capecitabine—colon cancer	0.000155	0.000831	CcSEcCtD
Tretinoin—Urethral disorder—Capecitabine—colon cancer	0.000154	0.000827	CcSEcCtD
Tretinoin—Paraesthesia—Vincristine—colon cancer	0.000154	0.000825	CcSEcCtD
Tretinoin—Anorexia—Fluorouracil—colon cancer	0.000153	0.000817	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000153	0.000817	CcSEcCtD
Tretinoin—Visual impairment—Capecitabine—colon cancer	0.000152	0.000813	CcSEcCtD
Tretinoin—Insomnia—Irinotecan—colon cancer	0.000151	0.00081	CcSEcCtD
Tretinoin—Paraesthesia—Irinotecan—colon cancer	0.00015	0.000804	CcSEcCtD
Tretinoin—Hypotension—Fluorouracil—colon cancer	0.00015	0.000801	CcSEcCtD
Tretinoin—Decreased appetite—Vincristine—colon cancer	0.000149	0.000799	CcSEcCtD
Tretinoin—Dyspnoea—Irinotecan—colon cancer	0.000149	0.000798	CcSEcCtD
Tretinoin—Erythema multiforme—Capecitabine—colon cancer	0.000149	0.000797	CcSEcCtD
Tretinoin—Somnolence—Irinotecan—colon cancer	0.000149	0.000796	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Vincristine—colon cancer	0.000148	0.000793	CcSEcCtD
Tretinoin—Fatigue—Vincristine—colon cancer	0.000148	0.000792	CcSEcCtD
Tretinoin—Eye disorder—Capecitabine—colon cancer	0.000147	0.000788	CcSEcCtD
Tretinoin—Dyspepsia—Irinotecan—colon cancer	0.000147	0.000788	CcSEcCtD
Tretinoin—Tinnitus—Capecitabine—colon cancer	0.000147	0.000786	CcSEcCtD
Tretinoin—Constipation—Vincristine—colon cancer	0.000147	0.000786	CcSEcCtD
Tretinoin—Pain—Vincristine—colon cancer	0.000147	0.000786	CcSEcCtD
Tretinoin—Asthma—Methotrexate—colon cancer	0.000146	0.000784	CcSEcCtD
Tretinoin—Flushing—Capecitabine—colon cancer	0.000146	0.000783	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000146	0.000781	CcSEcCtD
Tretinoin—Decreased appetite—Irinotecan—colon cancer	0.000145	0.000778	CcSEcCtD
Tretinoin—Insomnia—Fluorouracil—colon cancer	0.000145	0.000775	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000144	0.000773	CcSEcCtD
Tretinoin—Fatigue—Irinotecan—colon cancer	0.000144	0.000772	CcSEcCtD
Tretinoin—Paraesthesia—Fluorouracil—colon cancer	0.000144	0.00077	CcSEcCtD
Tretinoin—Pancreatitis—Methotrexate—colon cancer	0.000144	0.000769	CcSEcCtD
Tretinoin—Constipation—Irinotecan—colon cancer	0.000143	0.000765	CcSEcCtD
Tretinoin—Pain—Irinotecan—colon cancer	0.000143	0.000765	CcSEcCtD
Tretinoin—Angiopathy—Capecitabine—colon cancer	0.000143	0.000765	CcSEcCtD
Tretinoin—Dyspnoea—Fluorouracil—colon cancer	0.000143	0.000764	CcSEcCtD
Tretinoin—Somnolence—Fluorouracil—colon cancer	0.000142	0.000762	CcSEcCtD
Tretinoin—Chills—Capecitabine—colon cancer	0.000141	0.000757	CcSEcCtD
Tretinoin—Dyspepsia—Fluorouracil—colon cancer	0.000141	0.000755	CcSEcCtD
Tretinoin—Arrhythmia—Capecitabine—colon cancer	0.000141	0.000753	CcSEcCtD
Tretinoin—Abdominal discomfort—Methotrexate—colon cancer	0.00014	0.000752	CcSEcCtD
Tretinoin—Gastrointestinal pain—Vincristine—colon cancer	0.00014	0.000752	CcSEcCtD
Tretinoin—Decreased appetite—Fluorouracil—colon cancer	0.000139	0.000745	CcSEcCtD
Tretinoin—Alopecia—Capecitabine—colon cancer	0.000139	0.000745	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000138	0.00074	CcSEcCtD
Tretinoin—Mental disorder—Capecitabine—colon cancer	0.000138	0.000739	CcSEcCtD
Tretinoin—Feeling abnormal—Irinotecan—colon cancer	0.000138	0.000738	CcSEcCtD
Tretinoin—Erythema—Capecitabine—colon cancer	0.000137	0.000734	CcSEcCtD
Tretinoin—Malnutrition—Capecitabine—colon cancer	0.000137	0.000734	CcSEcCtD
Tretinoin—Neutropenia—Methotrexate—colon cancer	0.000137	0.000733	CcSEcCtD
Tretinoin—Dysuria—Methotrexate—colon cancer	0.000137	0.000733	CcSEcCtD
Tretinoin—Pain—Fluorouracil—colon cancer	0.000137	0.000733	CcSEcCtD
Tretinoin—Gastrointestinal pain—Irinotecan—colon cancer	0.000137	0.000732	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000136	0.000729	CcSEcCtD
Tretinoin—Abdominal pain—Vincristine—colon cancer	0.000136	0.000727	CcSEcCtD
Tretinoin—Body temperature increased—Vincristine—colon cancer	0.000136	0.000727	CcSEcCtD
Tretinoin—Flatulence—Capecitabine—colon cancer	0.000135	0.000723	CcSEcCtD
Tretinoin—Photosensitivity reaction—Methotrexate—colon cancer	0.000134	0.000716	CcSEcCtD
Tretinoin—Back pain—Capecitabine—colon cancer	0.000133	0.00071	CcSEcCtD
Tretinoin—Abdominal pain—Irinotecan—colon cancer	0.000132	0.000708	CcSEcCtD
Tretinoin—Body temperature increased—Irinotecan—colon cancer	0.000132	0.000708	CcSEcCtD
Tretinoin—Feeling abnormal—Fluorouracil—colon cancer	0.000132	0.000706	CcSEcCtD
Tretinoin—Pneumonia—Methotrexate—colon cancer	0.000131	0.000703	CcSEcCtD
Tretinoin—Infestation NOS—Methotrexate—colon cancer	0.000131	0.000699	CcSEcCtD
Tretinoin—Infestation—Methotrexate—colon cancer	0.000131	0.000699	CcSEcCtD
Tretinoin—Drowsiness—Methotrexate—colon cancer	0.000131	0.000699	CcSEcCtD
Tretinoin—Depression—Methotrexate—colon cancer	0.00013	0.000697	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000129	0.000693	CcSEcCtD
Tretinoin—Vision blurred—Capecitabine—colon cancer	0.000129	0.000692	CcSEcCtD
Tretinoin—Tremor—Capecitabine—colon cancer	0.000128	0.000688	CcSEcCtD
Tretinoin—Renal failure—Methotrexate—colon cancer	0.000128	0.000687	CcSEcCtD
Tretinoin—Stomatitis—Methotrexate—colon cancer	0.000127	0.000682	CcSEcCtD
Tretinoin—Ill-defined disorder—Capecitabine—colon cancer	0.000127	0.000681	CcSEcCtD
Tretinoin—Urticaria—Fluorouracil—colon cancer	0.000127	0.000681	CcSEcCtD
Tretinoin—Conjunctivitis—Methotrexate—colon cancer	0.000127	0.00068	CcSEcCtD
Tretinoin—Anaemia—Capecitabine—colon cancer	0.000127	0.000678	CcSEcCtD
Tretinoin—Body temperature increased—Fluorouracil—colon cancer	0.000127	0.000678	CcSEcCtD
Tretinoin—Hypersensitivity—Vincristine—colon cancer	0.000126	0.000677	CcSEcCtD
Tretinoin—Sweating—Methotrexate—colon cancer	0.000125	0.00067	CcSEcCtD
Tretinoin—Haematuria—Methotrexate—colon cancer	0.000124	0.000667	CcSEcCtD
Tretinoin—Malaise—Capecitabine—colon cancer	0.000124	0.000662	CcSEcCtD
Tretinoin—Epistaxis—Methotrexate—colon cancer	0.000123	0.00066	CcSEcCtD
Tretinoin—Hypersensitivity—Irinotecan—colon cancer	0.000123	0.000659	CcSEcCtD
Tretinoin—Asthenia—Vincristine—colon cancer	0.000123	0.000659	CcSEcCtD
Tretinoin—Syncope—Capecitabine—colon cancer	0.000123	0.000658	CcSEcCtD
Tretinoin—Agranulocytosis—Methotrexate—colon cancer	0.000122	0.000653	CcSEcCtD
Tretinoin—Palpitations—Capecitabine—colon cancer	0.000121	0.000649	CcSEcCtD
Tretinoin—Loss of consciousness—Capecitabine—colon cancer	0.00012	0.000645	CcSEcCtD
Tretinoin—Asthenia—Irinotecan—colon cancer	0.00012	0.000642	CcSEcCtD
Tretinoin—Cough—Capecitabine—colon cancer	0.00012	0.000641	CcSEcCtD
Tretinoin—Hypertension—Capecitabine—colon cancer	0.000118	0.000634	CcSEcCtD
Tretinoin—Hypersensitivity—Fluorouracil—colon cancer	0.000118	0.000632	CcSEcCtD
Tretinoin—Haemoglobin—Methotrexate—colon cancer	0.000118	0.000631	CcSEcCtD
Tretinoin—Diarrhoea—Vincristine—colon cancer	0.000117	0.000629	CcSEcCtD
Tretinoin—Haemorrhage—Methotrexate—colon cancer	0.000117	0.000628	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—colon cancer	0.000117	0.000628	CcSEcCtD
Tretinoin—Arthralgia—Capecitabine—colon cancer	0.000117	0.000625	CcSEcCtD
Tretinoin—Myalgia—Capecitabine—colon cancer	0.000117	0.000625	CcSEcCtD
Tretinoin—Chest pain—Capecitabine—colon cancer	0.000117	0.000625	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—colon cancer	0.000116	0.000623	CcSEcCtD
Tretinoin—Anxiety—Capecitabine—colon cancer	0.000116	0.000623	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000116	0.000621	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—colon cancer	0.000116	0.00062	CcSEcCtD
Tretinoin—Discomfort—Capecitabine—colon cancer	0.000115	0.000617	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—colon cancer	0.000115	0.000615	CcSEcCtD
Tretinoin—Diarrhoea—Irinotecan—colon cancer	0.000114	0.000612	CcSEcCtD
Tretinoin—Dry mouth—Capecitabine—colon cancer	0.000114	0.000611	CcSEcCtD
Tretinoin—Dizziness—Vincristine—colon cancer	0.000113	0.000608	CcSEcCtD
Tretinoin—Pruritus—Fluorouracil—colon cancer	0.000113	0.000607	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—colon cancer	0.000113	0.000605	CcSEcCtD
Tretinoin—Confusional state—Capecitabine—colon cancer	0.000113	0.000604	CcSEcCtD
Tretinoin—Oedema—Capecitabine—colon cancer	0.000112	0.000599	CcSEcCtD
Tretinoin—Infection—Capecitabine—colon cancer	0.000111	0.000595	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—colon cancer	0.000111	0.000593	CcSEcCtD
Tretinoin—Dizziness—Irinotecan—colon cancer	0.00011	0.000592	CcSEcCtD
Tretinoin—Shock—Capecitabine—colon cancer	0.00011	0.000589	CcSEcCtD
Tretinoin—Nervous system disorder—Capecitabine—colon cancer	0.00011	0.000587	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—colon cancer	0.000109	0.000587	CcSEcCtD
Tretinoin—Diarrhoea—Fluorouracil—colon cancer	0.000109	0.000587	CcSEcCtD
Tretinoin—Thrombocytopenia—Capecitabine—colon cancer	0.000109	0.000587	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—colon cancer	0.000109	0.000585	CcSEcCtD
Tretinoin—Tachycardia—Capecitabine—colon cancer	0.000109	0.000585	CcSEcCtD
Tretinoin—Vomiting—Vincristine—colon cancer	0.000109	0.000584	CcSEcCtD
Tretinoin—Skin disorder—Capecitabine—colon cancer	0.000109	0.000582	CcSEcCtD
Tretinoin—Rash—Vincristine—colon cancer	0.000108	0.000579	CcSEcCtD
Tretinoin—Hyperhidrosis—Capecitabine—colon cancer	0.000108	0.000579	CcSEcCtD
Tretinoin—Dermatitis—Vincristine—colon cancer	0.000108	0.000579	CcSEcCtD
Tretinoin—Headache—Vincristine—colon cancer	0.000107	0.000576	CcSEcCtD
Tretinoin—Anorexia—Capecitabine—colon cancer	0.000107	0.000571	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—colon cancer	0.000106	0.00057	CcSEcCtD
Tretinoin—Vomiting—Irinotecan—colon cancer	0.000106	0.000569	CcSEcCtD
Tretinoin—Dizziness—Fluorouracil—colon cancer	0.000106	0.000567	CcSEcCtD
Tretinoin—Rash—Irinotecan—colon cancer	0.000105	0.000564	CcSEcCtD
Tretinoin—Dermatitis—Irinotecan—colon cancer	0.000105	0.000564	CcSEcCtD
Tretinoin—Chills—Methotrexate—colon cancer	0.000105	0.000563	CcSEcCtD
Tretinoin—Headache—Irinotecan—colon cancer	0.000105	0.000561	CcSEcCtD
Tretinoin—Hypotension—Capecitabine—colon cancer	0.000104	0.00056	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—colon cancer	0.000104	0.000555	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—colon cancer	0.000103	0.00055	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—colon cancer	0.000102	0.000546	CcSEcCtD
Tretinoin—Erythema—Methotrexate—colon cancer	0.000102	0.000546	CcSEcCtD
Tretinoin—Nausea—Vincristine—colon cancer	0.000102	0.000546	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000102	0.000546	CcSEcCtD
Tretinoin—Vomiting—Fluorouracil—colon cancer	0.000102	0.000545	CcSEcCtD
Tretinoin—Insomnia—Capecitabine—colon cancer	0.000101	0.000542	CcSEcCtD
Tretinoin—Rash—Fluorouracil—colon cancer	0.000101	0.000541	CcSEcCtD
Tretinoin—Dermatitis—Fluorouracil—colon cancer	0.000101	0.00054	CcSEcCtD
Tretinoin—Paraesthesia—Capecitabine—colon cancer	0.0001	0.000538	CcSEcCtD
Tretinoin—Headache—Fluorouracil—colon cancer	0.0001	0.000537	CcSEcCtD
Tretinoin—Dyspnoea—Capecitabine—colon cancer	9.97e-05	0.000534	CcSEcCtD
Tretinoin—Nausea—Irinotecan—colon cancer	9.92e-05	0.000532	CcSEcCtD
Tretinoin—Back pain—Methotrexate—colon cancer	9.87e-05	0.000529	CcSEcCtD
Tretinoin—Dyspepsia—Capecitabine—colon cancer	9.84e-05	0.000527	CcSEcCtD
Tretinoin—Decreased appetite—Capecitabine—colon cancer	9.72e-05	0.000521	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Capecitabine—colon cancer	9.65e-05	0.000517	CcSEcCtD
Tretinoin—Fatigue—Capecitabine—colon cancer	9.64e-05	0.000516	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—colon cancer	9.61e-05	0.000515	CcSEcCtD
Tretinoin—Constipation—Capecitabine—colon cancer	9.56e-05	0.000512	CcSEcCtD
Tretinoin—Pain—Capecitabine—colon cancer	9.56e-05	0.000512	CcSEcCtD
Tretinoin—Nausea—Fluorouracil—colon cancer	9.51e-05	0.000509	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—colon cancer	9.46e-05	0.000507	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—colon cancer	9.43e-05	0.000505	CcSEcCtD
Tretinoin—Feeling abnormal—Capecitabine—colon cancer	9.21e-05	0.000494	CcSEcCtD
Tretinoin—Malaise—Methotrexate—colon cancer	9.2e-05	0.000493	CcSEcCtD
Tretinoin—Gastrointestinal pain—Capecitabine—colon cancer	9.14e-05	0.00049	CcSEcCtD
Tretinoin—Cough—Methotrexate—colon cancer	8.9e-05	0.000477	CcSEcCtD
Tretinoin—Urticaria—Capecitabine—colon cancer	8.88e-05	0.000476	CcSEcCtD
Tretinoin—Abdominal pain—Capecitabine—colon cancer	8.84e-05	0.000474	CcSEcCtD
Tretinoin—Body temperature increased—Capecitabine—colon cancer	8.84e-05	0.000474	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—colon cancer	8.84e-05	0.000473	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—colon cancer	8.68e-05	0.000465	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—colon cancer	8.68e-05	0.000465	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—colon cancer	8.68e-05	0.000465	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	8.62e-05	0.000462	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—colon cancer	8.58e-05	0.00046	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—colon cancer	8.39e-05	0.00045	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—colon cancer	8.32e-05	0.000446	CcSEcCtD
Tretinoin—Infection—Methotrexate—colon cancer	8.27e-05	0.000443	CcSEcCtD
Tretinoin—Hypersensitivity—Capecitabine—colon cancer	8.24e-05	0.000441	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—colon cancer	8.16e-05	0.000437	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—colon cancer	8.15e-05	0.000437	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—colon cancer	8.09e-05	0.000433	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—colon cancer	8.05e-05	0.000431	CcSEcCtD
Tretinoin—Asthenia—Capecitabine—colon cancer	8.02e-05	0.00043	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—colon cancer	7.94e-05	0.000425	CcSEcCtD
Tretinoin—Pruritus—Capecitabine—colon cancer	7.91e-05	0.000424	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—colon cancer	7.78e-05	0.000417	CcSEcCtD
Tretinoin—RARA—Gene Expression—HNF4A—colon cancer	7.78e-05	0.000683	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—HNF4A—colon cancer	7.78e-05	0.000683	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	7.76e-05	0.000681	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.76e-05	0.000681	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	7.72e-05	0.000677	CbGpPWpGaD
Tretinoin—Diarrhoea—Capecitabine—colon cancer	7.65e-05	0.00041	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	7.63e-05	0.000669	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Methotrexate—colon cancer	7.58e-05	0.000406	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—colon cancer	7.53e-05	0.000403	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	7.52e-05	0.00066	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	7.52e-05	0.00066	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—EP300—colon cancer	7.49e-05	0.000657	CbGpPWpGaD
Tretinoin—Paraesthesia—Methotrexate—colon cancer	7.47e-05	0.0004	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—PPARG—colon cancer	7.46e-05	0.000655	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ODC1—colon cancer	7.44e-05	0.000653	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CHST5—colon cancer	7.44e-05	0.000653	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	7.44e-05	0.000653	CbGpPWpGaD
Tretinoin—Dyspnoea—Methotrexate—colon cancer	7.42e-05	0.000398	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—colon cancer	7.4e-05	0.000396	CcSEcCtD
Tretinoin—Dizziness—Capecitabine—colon cancer	7.39e-05	0.000396	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—colon cancer	7.33e-05	0.000393	CcSEcCtD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	7.33e-05	0.000643	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	7.32e-05	0.000642	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	7.32e-05	0.000642	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—PPARG—colon cancer	7.32e-05	0.000642	CbGpPWpGaD
Tretinoin—Decreased appetite—Methotrexate—colon cancer	7.24e-05	0.000388	CcSEcCtD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.21e-05	0.000633	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Methotrexate—colon cancer	7.19e-05	0.000385	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—colon cancer	7.18e-05	0.000384	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	7.13e-05	0.000626	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	7.13e-05	0.000625	CbGpPWpGaD
Tretinoin—Pain—Methotrexate—colon cancer	7.12e-05	0.000381	CcSEcCtD
Tretinoin—Vomiting—Capecitabine—colon cancer	7.11e-05	0.000381	CcSEcCtD
Tretinoin—Rash—Capecitabine—colon cancer	7.05e-05	0.000378	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—CTNNB1—colon cancer	7.05e-05	0.000619	CbGpPWpGaD
Tretinoin—Dermatitis—Capecitabine—colon cancer	7.04e-05	0.000377	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	7.04e-05	0.000618	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARG—colon cancer	7.01e-05	0.000616	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—PPARG—colon cancer	7.01e-05	0.000616	CbGpPWpGaD
Tretinoin—Headache—Capecitabine—colon cancer	7.01e-05	0.000375	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.9e-05	0.000605	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—CDKN1A—colon cancer	6.88e-05	0.000604	CbGpPWpGaD
Tretinoin—Feeling abnormal—Methotrexate—colon cancer	6.86e-05	0.000367	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.83e-05	0.0006	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Methotrexate—colon cancer	6.81e-05	0.000365	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—CA7—colon cancer	6.66e-05	0.000584	CbGpPWpGaD
Tretinoin—Nausea—Capecitabine—colon cancer	6.64e-05	0.000356	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.64e-05	0.000583	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.64e-05	0.000583	CbGpPWpGaD
Tretinoin—Urticaria—Methotrexate—colon cancer	6.61e-05	0.000354	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	6.61e-05	0.00058	CbGpPWpGaD
Tretinoin—Abdominal pain—Methotrexate—colon cancer	6.58e-05	0.000353	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—colon cancer	6.58e-05	0.000353	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	6.56e-05	0.000576	CbGpPWpGaD
Tretinoin—CYP4A11—NRF2 pathway—TGFB1—colon cancer	6.54e-05	0.000574	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	6.54e-05	0.000574	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CA7—colon cancer	6.51e-05	0.000571	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ABCB1—colon cancer	6.5e-05	0.00057	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ABCB1—colon cancer	6.5e-05	0.00057	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ABCB1—colon cancer	6.5e-05	0.00057	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	6.41e-05	0.000563	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	6.41e-05	0.000563	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—TYMS—colon cancer	6.38e-05	0.00056	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—TYMS—colon cancer	6.38e-05	0.00056	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—TYMS—colon cancer	6.38e-05	0.00056	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	6.37e-05	0.000559	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	6.31e-05	0.000554	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CA7—colon cancer	6.15e-05	0.00054	CbGpPWpGaD
Tretinoin—Hypersensitivity—Methotrexate—colon cancer	6.13e-05	0.000329	CcSEcCtD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	6.06e-05	0.000532	CbGpPWpGaD
Tretinoin—Asthenia—Methotrexate—colon cancer	5.97e-05	0.00032	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—colon cancer	5.89e-05	0.000316	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.82e-05	0.000511	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.79e-05	0.000508	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—MYC—colon cancer	5.77e-05	0.000506	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	5.73e-05	0.000503	CbGpPWpGaD
Tretinoin—Diarrhoea—Methotrexate—colon cancer	5.7e-05	0.000305	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—TGFB1—colon cancer	5.69e-05	0.0005	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CA7—colon cancer	5.64e-05	0.000495	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	5.6e-05	0.000492	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	5.58e-05	0.00049	CbGpPWpGaD
Tretinoin—Dizziness—Methotrexate—colon cancer	5.5e-05	0.000295	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—ODC1—colon cancer	5.45e-05	0.000479	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CHST5—colon cancer	5.45e-05	0.000479	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.37e-05	0.000472	CbGpPWpGaD
Tretinoin—Vomiting—Methotrexate—colon cancer	5.29e-05	0.000284	CcSEcCtD
Tretinoin—Rash—Methotrexate—colon cancer	5.25e-05	0.000281	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—colon cancer	5.24e-05	0.000281	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.23e-05	0.000459	CbGpPWpGaD
Tretinoin—Headache—Methotrexate—colon cancer	5.21e-05	0.000279	CcSEcCtD
Tretinoin—RXRA—NRF2 pathway—TGFB1—colon cancer	5.19e-05	0.000455	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.18e-05	0.000455	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	5.15e-05	0.000452	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	5.06e-05	0.000444	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	5.05e-05	0.000443	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ODC1—colon cancer	5e-05	0.000439	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CHST5—colon cancer	5e-05	0.000439	CbGpPWpGaD
Tretinoin—Nausea—Methotrexate—colon cancer	4.94e-05	0.000265	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.91e-05	0.000431	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.91e-05	0.000431	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—PPARG—colon cancer	4.87e-05	0.000428	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.81e-05	0.000423	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.68e-05	0.000411	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—MYC—colon cancer	4.65e-05	0.000408	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CA7—colon cancer	4.59e-05	0.000403	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.56e-05	0.0004	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARG—colon cancer	4.52e-05	0.000397	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PPARG—colon cancer	4.52e-05	0.000397	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARG—colon cancer	4.52e-05	0.000397	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—MYC—colon cancer	4.25e-05	0.000373	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—colon cancer	4.2e-05	0.000369	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.2e-05	0.000368	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.19e-05	0.000367	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—MYC—colon cancer	4.17e-05	0.000366	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.1e-05	0.00036	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—HNF4A—colon cancer	4.05e-05	0.000356	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CHST5—colon cancer	4.03e-05	0.000354	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ODC1—colon cancer	4.03e-05	0.000354	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—MYC—colon cancer	4e-05	0.000351	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—MYC—colon cancer	4e-05	0.000351	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ODC1—colon cancer	3.94e-05	0.000346	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CHST5—colon cancer	3.94e-05	0.000346	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—PPARG—colon cancer	3.93e-05	0.000345	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	3.88e-05	0.00034	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.87e-05	0.00034	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	3.86e-05	0.000339	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—EP300—colon cancer	3.75e-05	0.000329	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CHST5—colon cancer	3.72e-05	0.000327	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ODC1—colon cancer	3.72e-05	0.000327	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	3.67e-05	0.000322	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—PPARG—colon cancer	3.66e-05	0.000321	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—PPARG—colon cancer	3.59e-05	0.000315	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.56e-05	0.000313	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—colon cancer	3.56e-05	0.000312	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—colon cancer	3.56e-05	0.000312	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—colon cancer	3.56e-05	0.000312	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—PPARG—colon cancer	3.52e-05	0.000309	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFB1—colon cancer	3.48e-05	0.000306	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.45e-05	0.000302	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARG—colon cancer	3.44e-05	0.000302	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ODC1—colon cancer	3.41e-05	0.0003	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CHST5—colon cancer	3.41e-05	0.0003	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARG—colon cancer	3.38e-05	0.000296	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARG—colon cancer	3.38e-05	0.000296	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.07e-05	0.00027	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.05e-05	0.000268	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA7—colon cancer	3.03e-05	0.000266	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—EP300—colon cancer	2.96e-05	0.00026	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—EP300—colon cancer	2.96e-05	0.00026	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—EP300—colon cancer	2.96e-05	0.00026	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	2.91e-05	0.000255	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CHST5—colon cancer	2.78e-05	0.000244	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ODC1—colon cancer	2.78e-05	0.000244	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—MYC—colon cancer	2.78e-05	0.000244	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.53e-05	0.000222	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	2.53e-05	0.000222	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ABCB1—colon cancer	2.48e-05	0.000218	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—TYMS—colon cancer	2.44e-05	0.000214	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—CTNNB1—colon cancer	2.42e-05	0.000213	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.42e-05	0.000212	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EP300—colon cancer	2.25e-05	0.000198	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—colon cancer	2.24e-05	0.000197	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—SRC—colon cancer	2.19e-05	0.000192	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CA—colon cancer	2.19e-05	0.000192	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CA—colon cancer	2.19e-05	0.000192	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CA—colon cancer	2.19e-05	0.000192	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ABCB1—colon cancer	2.17e-05	0.00019	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—VEGFA—colon cancer	2.13e-05	0.000187	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—TYMS—colon cancer	2.13e-05	0.000187	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—NRAS—colon cancer	2.11e-05	0.000185	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—colon cancer	2.08e-05	0.000183	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—colon cancer	2.05e-05	0.00018	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.01e-05	0.000176	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—colon cancer	2.01e-05	0.000176	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ABCB1—colon cancer	1.97e-05	0.000173	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TGFB1—colon cancer	1.96e-05	0.000172	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—TYMS—colon cancer	1.93e-05	0.00017	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—AKT1—colon cancer	1.93e-05	0.000169	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—colon cancer	1.93e-05	0.000169	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—colon cancer	1.93e-05	0.000169	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—colon cancer	1.92e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.88e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ODC1—colon cancer	1.83e-05	0.000161	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CHST5—colon cancer	1.83e-05	0.000161	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—KRAS—colon cancer	1.81e-05	0.000159	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AKT1—colon cancer	1.79e-05	0.000157	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AKT1—colon cancer	1.79e-05	0.000157	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AKT1—colon cancer	1.79e-05	0.000157	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—colon cancer	1.76e-05	0.000154	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—colon cancer	1.73e-05	0.000151	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—AKT1—colon cancer	1.55e-05	0.000136	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—HRAS—colon cancer	1.54e-05	0.000135	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.54e-05	0.000135	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—colon cancer	1.51e-05	0.000132	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.49e-05	0.000131	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—colon cancer	1.44e-05	0.000126	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—colon cancer	1.42e-05	0.000125	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—TYMS—colon cancer	1.42e-05	0.000124	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.41e-05	0.000124	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—colon cancer	1.39e-05	0.000122	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—colon cancer	1.37e-05	0.00012	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—colon cancer	1.36e-05	0.000119	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—colon cancer	1.36e-05	0.000119	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—colon cancer	1.34e-05	0.000117	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—colon cancer	1.34e-05	0.000117	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—colon cancer	1.32e-05	0.000116	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—TYMS—colon cancer	1.3e-05	0.000114	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.21e-05	0.000106	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—colon cancer	1.19e-05	0.000104	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.15e-05	0.000101	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—colon cancer	1.13e-05	9.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.11e-05	9.73e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—colon cancer	1.08e-05	9.45e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—colon cancer	1.07e-05	9.36e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TYMS—colon cancer	1.05e-05	9.19e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—colon cancer	1.04e-05	9.14e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TYMS—colon cancer	1.02e-05	8.98e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.01e-05	8.83e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—colon cancer	1e-05	8.81e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—colon cancer	1e-05	8.8e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—colon cancer	9.87e-06	8.66e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—colon cancer	9.84e-06	8.64e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TYMS—colon cancer	9.67e-06	8.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.22e-06	8.09e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—colon cancer	9.19e-06	8.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.03e-06	7.92e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—colon cancer	9.02e-06	7.92e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—colon cancer	8.95e-06	7.86e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TYMS—colon cancer	8.86e-06	7.78e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—colon cancer	8.35e-06	7.33e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—colon cancer	7.89e-06	6.92e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.51e-06	6.59e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.44e-06	6.53e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—colon cancer	7.42e-06	6.51e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—colon cancer	7.34e-06	6.45e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—colon cancer	7.3e-06	6.41e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—colon cancer	7.25e-06	6.36e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—colon cancer	7.23e-06	6.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TYMS—colon cancer	7.21e-06	6.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—colon cancer	6.96e-06	6.11e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—colon cancer	6.85e-06	6.01e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.82e-06	5.99e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—colon cancer	6.82e-06	5.99e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—colon cancer	6.62e-06	5.81e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—colon cancer	6.56e-06	5.76e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—colon cancer	6.28e-06	5.51e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—colon cancer	6.01e-06	5.28e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—colon cancer	5.96e-06	5.23e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—colon cancer	5.83e-06	5.12e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—colon cancer	5.7e-06	5e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.55e-06	4.87e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—colon cancer	5.41e-06	4.75e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—colon cancer	5.39e-06	4.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—colon cancer	5.11e-06	4.48e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—colon cancer	4.94e-06	4.33e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—colon cancer	4.85e-06	4.26e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—colon cancer	4.85e-06	4.26e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—colon cancer	4.84e-06	4.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TYMS—colon cancer	4.76e-06	4.18e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—colon cancer	4.74e-06	4.16e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—colon cancer	4.48e-06	3.93e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—colon cancer	4.45e-06	3.9e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—colon cancer	4.11e-06	3.61e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—colon cancer	4.02e-06	3.53e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—colon cancer	3.96e-06	3.48e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—colon cancer	3.63e-06	3.19e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—colon cancer	3.59e-06	3.15e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—colon cancer	3.51e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—colon cancer	3.37e-06	2.96e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—colon cancer	3.34e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—colon cancer	3.31e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—colon cancer	3.04e-06	2.67e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—colon cancer	2.93e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—colon cancer	2.87e-06	2.52e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—colon cancer	2.71e-06	2.38e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—colon cancer	2.65e-06	2.33e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—colon cancer	2.48e-06	2.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—colon cancer	2.47e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—colon cancer	2.2e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—colon cancer	2.02e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.63e-06	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—colon cancer	1.33e-06	1.17e-05	CbGpPWpGaD
